Representative Tim Moore (R-North Carolina) recently bought shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on September 03rd, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on August 1st.
Representative Tim Moore also recently made the following trade(s):
- Sold $100,001 - $250,000 in shares of Centene NYSE: CNC on 8/18/2025.
- Sold $50,001 - $100,000 in shares of UnitedHealth Group NYSE: UNH on 8/15/2025.
- Sold $100,001 - $250,000 in shares of Intel NASDAQ: INTC on 8/13/2025.
- Sold $50,001 - $100,000 in shares of Hyster-Yale NYSE: HY on 8/13/2025.
- Purchased $15,001 - $50,000 in shares of Hyster-Yale NYSE: HY on 8/12/2025.
- Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 8/11/2025.
- Purchased $15,001 - $50,000 in shares of UnitedHealth Group NYSE: UNH on 8/8/2025.
- Purchased $1,001 - $15,000 in shares of Centene NYSE: CNC on 8/8/2025.
- Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 8/8/2025.
- Purchased $15,001 - $50,000 in shares of Hyster-Yale NYSE: HY on 8/7/2025.
UnitedHealth Group Stock Up 0.7%
NYSE:UNH opened at $309.98 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a fifty day simple moving average of $288.66 and a 200-day simple moving average of $375.70. The company has a market cap of $280.74 billion, a price-to-earnings ratio of 13.43, a price-to-earnings-growth ratio of 1.99 and a beta of 0.45. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business's revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.
Institutional Investors Weigh In On UnitedHealth Group
A number of hedge funds have recently bought and sold shares of UNH. Norges Bank acquired a new stake in UnitedHealth Group in the 2nd quarter valued at about $3,837,207,000. GAMMA Investing LLC grew its stake in UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Nuveen LLC purchased a new position in shares of UnitedHealth Group in the 1st quarter valued at approximately $3,846,764,000. Vanguard Group Inc. grew its stake in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Finally, Berkshire Hathaway Inc acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $1,572,193,000. Institutional investors and hedge funds own 87.86% of the company's stock.
Analyst Ratings Changes
A number of equities analysts have commented on the stock. Baird R W downgraded shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Morgan Stanley dropped their target price on UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 20th. Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Hsbc Global Res downgraded UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Finally, Piper Sandler dropped their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Fifteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $353.71.
Check Out Our Latest Stock Analysis on UnitedHealth Group
Insider Transactions at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 0.28% of the company's stock.
About Representative Moore
Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina's 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Moore (Republican Party) ran for election to the U.S. House to represent North Carolina's 14th Congressional District. He won in the general election on November 5, 2024.
Moore served as speaker of the House from 2015 to 2025.
Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.
About UnitedHealth Group
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
